[Undesired cutaneous adverse drug reactions: What is new?].
New therapeutic agents, i.e., biologicals, may induce a variety of novel cutaneous adverse reactions (CAR), which hardly can be assigned to existing classification systems. Basing on clinical examples, we present a recently established classification system for CAR to novel drugs. In addition, management strategies for CAR to tumor necrosis factor-α antagonists and to epidermal growth factor receptor inhibitors are discussed.
Klinik für Dermatologie, Venerologie und Allergologie, Universität Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland. regina.treudler@uniklinik-leipzig.de
R
R
Treudler
J C
JC
Simon
D001688:Biological Products / Q000009:adverse effects* / Q000145:classification*; D003875:Drug Eruptions / Q000145:classification* / Q000209:etiology*; D005858:Germany; D006801:Humans
D001688:Biological Products